Inhaled triple therapy in chronic obstructive pulmonary disease

Slides:



Advertisements
Similar presentations
Mucosal Immunology of Food Allergy M. Cecilia Berin, Hugh A. Sampson Current Biology Volume 23, Issue 9, Pages R389-R400 (May 2013) DOI: /j.cub
Advertisements

The Circadian Timekeeping System of Drosophila Paul E. Hardin Current Biology Volume 15, Issue 17, Pages R714-R722 (September 2005) DOI: /j.cub
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease S. Karia, R. Mahadeva, A. Balan, J. Babar Clinical Radiology.
The Origins and Evolution of Vertebrate Metamorphosis Vincent Laudet Current Biology Volume 21, Issue 18, Pages R726-R737 (September 2011) DOI: /j.cub
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 390, Issue 10098, Pages (September 2017)
ZIKA App – A great resource from the World Health Organization (WHO)
Antimicrobial therapy to prevent or treat oral mucositis
Thank God for Richard Dawkins?
Long-term effects of hormone replacement therapy
Simple versus complex COPD: implications for health-care management
Brian J Coburn, David J Gerberry, Sally Blower 
At high risk: becoming a mother in the Peruvian Andes
Volume 153, Issue 4, Pages (April 2018)
Infections related to totally implantable venous-access ports
Low-level laser therapy for neck pain
Blood eosinophils as a marker of eosinophilic exacerbations in COPD
Long-term effects of hormone replacement therapy
Precision Medicine Urgency
Klebsiella pneumoniae liver abscesses
Improving Adherence for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease  Lindsay Sonstein, MD, Carlos Clark, DO, Susan Seidensticker,
Do air quality alerts benefit public health? New evidence from Canada
Genetics of lung cancer susceptibility and COPD
Coeliac disease The Lancet
Drug therapy for coronary heart disease: the Sheffield table
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Gene therapy—where are we?
Treatment of Helicobacter pylori in Latin America
Effective cross-sector collaborations create sustainability
Volume 382, Issue 9906, Pages (November 2013)
Brian J Coburn, Sally Blower  The Lancet Infectious Diseases 
A next-generation Alzheimer's centre for Madrid
Disease and stigma The Lancet Volume 354, (December 1999)
Arnaud Chiolero  The Lancet Public Health 
HIV myths should not be resuscitated
Effect of development assistance on domestic health expenditures
Volume 362, Pages s6-s7 (December 2003)
Adrian Martineau  The Lancet Respiratory Medicine 
Cold water immersion: sudden death and prolonged survival
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double- blind, parallel-group, placebo-controlled trial  Dr Andrew R Goudie,
Anti-interleukin 13 for asthma: stick or twist?
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
Telling it like it isn't: truth and lies in a post-9/11 world
Chronic obstructive pulmonary disease in non-smokers
Thank God for Richard Dawkins?
Low-technology approaches
Diagnosis of tuberculous meningitis with invasive pulmonary sampling
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Volume 377, Issue 9777, Pages (May 2011)
PM2·5: an important cause for chronic obstructive pulmonary disease?
ACST: which subgroups will benefit most from carotid endarterectomy?
Debate on long-acting β agonists for asthma: they think it's all over
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Costs of eliminating HIV in South Africa have been underestimated
GBD 2016 estimates problematic for South Africa
Infections related to totally implantable venous-access ports
Children and adolescents with HIV
Liver failure after long-term nucleoside antiretroviral therapy
A remarkable report card on progress in COPD
Difficulties of surgery in the developing world: a personal view
Volume 21, Issue 9, Pages (September 2014)
A 12 year outbreak of scarlet fever in Singapore
Refining treatment choices for ADHD
Volume 21, Issue 9, Pages (September 2014)
Symptom-based stratification of autoimmune diseases
Sickle cell disease: a new era
Autism, maths, and sex: the special triangle
Presentation transcript:

Inhaled triple therapy in chronic obstructive pulmonary disease Brian Lipworth, Chris RuiWen Kuo, Sunny Jabbal  The Lancet  Volume 392, Issue 10153, Pages 1112-1113 (September 2018) DOI: 10.1016/S0140-6736(18)31795-1 Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure The effects of inhaled corticosteroid moiety of single-inhaler triple therapy in chronic obstructive pulmonary disease Benefits include attenuation of bronchial mucosal eosinophilic inflammation resulting in reduced exacerbations and risks include altered microbiome along with prolonged alveolar inhaled corticosteroid retention and local immunosuppression resulting in an increased risk of pneumonia. The Lancet 2018 392, 1112-1113DOI: (10.1016/S0140-6736(18)31795-1) Copyright © 2018 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.